paroxetine has been researched along with Huntington Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantor, S; Kulkarni, S; Morton, AJ; Varga, J | 1 |
| Aungier, J; Cuesta, M; Morton, AJ; Ouk, K | 1 |
| Betti, L; Bonuccelli, U; Ceravolo, R; Giannaccini, G; Kiferle, L; Mazzucchi, S; Palego, L; Palermo, G; Unti, E | 1 |
| Belcher, DC; Dowben, JS; Keltner, NL; Kowalski, PC | 1 |
| Cadet, JL; Duan, W; Guo, Z; Jiang, H; Ladenheim, B; Mattson, MP; Xu, X | 1 |
| Cross, AJ; Reynolds, GP; Slater, P | 1 |
1 review(s) available for paroxetine and Huntington Disease
| Article | Year |
|---|---|
Biological Perspectives: Huntington's Disease.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Cognition Disorders; Dementia; Humans; Huntington Disease; Magnetic Resonance Imaging; Male; Memory, Short-Term; Mood Disorders; Olanzapine; Paroxetine | 2015 |
5 other study(ies) available for paroxetine and Huntington Disease
| Article | Year |
|---|---|
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
Topics: Animals; Brain; Brain Waves; Huntington Disease; Male; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep Wake Disorders | 2017 |
Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.
Topics: Animals; Central Nervous System Stimulants; Circadian Clocks; Circadian Rhythm; Cocaine; Disease Models, Animal; Female; Huntington Disease; Male; Methamphetamine; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Motor Activity; Paroxetine; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Vesicular Monoamine Transport Proteins | 2018 |
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington's Disease: Relationships with Social Cognition Symptoms.
Topics: Aged; Aged, 80 and over; Anger; Blood Platelets; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Humans; Huntington Disease; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Paroxetine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Social Perception; Voice | 2018 |
Paroxetine retards disease onset and progression in Huntingtin mutant mice.
Topics: Animals; Disease Progression; Female; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Paroxetine | 2004 |
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
Topics: Aged; Aspartic Acid; Brain; Caudate Nucleus; Female; Frontal Lobe; Glutamates; Glutamic Acid; Hippocampus; Humans; Huntington Disease; Male; Middle Aged; Paroxetine; Piperidines; Putamen | 1986 |